Showing results (51-60 of 3,871) with videos related to
Sort By:
Pageof 388
The Journal of Laryngology and Otology|April 8, 2004
Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virusT Powles, J Powles, M Nelson, et al.Postgraduate Medical Journal|April 17, 2003
Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumoniaN Lubis, D Baylis, A Short, et al.The Journal of Antimicrobial Chemotherapy|June 18, 2004
A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 countsL Waters, J Stebbing, R Jones, et al.Postgraduate Medical Journal|January 7, 2004
Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART eraS H Allen, P Brennan-Benson, M Nelson, et al.The Journal of Antimicrobial Chemotherapy|July 1, 2008
Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patientsC Herzmann, Z Cuthbertson, L Fosdick, et al.AIDS (London, England)|February 1, 1988
Restriction of sensitivity of HIV-1-antigen ELISA by serum anti-core antibodiesK N Tsiquaye, M Youle, A C ChanasHIV Medicine|September 2, 2006
Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapyC Palmieri, T Dhillon, C Thirlwell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppressionM Alfa-Wali, T Allen-Mersh, A Antoniou, et al.AIDS Research and Human Retroviruses|January 16, 1998
A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokinesJ B Marriott, S Cookson, E Carlin, et al.International Journal of STD & AIDS|September 16, 2000
HIV-associated Hodgkin's diseaseT Powles, M BowerPageof 388